<DOC>
	<DOCNO>NCT00909571</DOCNO>
	<brief_summary>Tacrolimus pharmacokinetics study primary living donor liver transplantation patient Tacrolimus base immunosuppressive regimen .</brief_summary>
	<brief_title>Pharmacokinetics Tacrolimus Liver Transplantation Patients Treated With Prograf Modified Release Tacrolimus</brief_title>
	<detailed_description>To describe pharmacokinetics Tacrolimus administer two different dos modify release formulation FK506E ( MR4 ) combine Prograf injection patient undergoing primary living donor liver transplantation base single center ( Asan Medical Center ) standard protocol regimen .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patients receive primary partial liver graft live donor Patients must receive first dose Tacrolimus surgery expect maintain Tacrolimus throughout study Patients receive multiorgan transplantation previously receive organ transplantation Patients receive auxiliary graft bioartificial liver use Patients allergic intolerant macrolide antibody Tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>FK506E</keyword>
	<keyword>MR4</keyword>
	<keyword>Prograf</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Living Liver Transplantation</keyword>
</DOC>